Vaughan David Investments LLC IL Grows Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Vaughan David Investments LLC IL raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRGGet Rating) by 200.0% during the 4th quarter, HoldingsChannel.com reports. The fund owned 1,077 shares of the medical equipment provider’s stock after acquiring an additional 718 shares during the quarter. Vaughan David Investments LLC IL’s holdings in Intuitive Surgical were worth $387,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in ISRG. Hexagon Capital Partners LLC raised its holdings in shares of Intuitive Surgical by 200.0% during the 4th quarter. Hexagon Capital Partners LLC now owns 69 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 46 shares in the last quarter. Paragon Capital Management Ltd purchased a new position in shares of Intuitive Surgical during the 4th quarter valued at about $26,000. Hanseatic Management Services Inc. raised its holdings in shares of Intuitive Surgical by 200.0% during the 4th quarter. Hanseatic Management Services Inc. now owns 72 shares of the medical equipment provider’s stock valued at $26,000 after buying an additional 48 shares in the last quarter. Wolff Wiese Magana LLC raised its holdings in shares of Intuitive Surgical by 1,000.0% during the 4th quarter. Wolff Wiese Magana LLC now owns 77 shares of the medical equipment provider’s stock valued at $28,000 after buying an additional 70 shares in the last quarter. Finally, Sargent Bickham Lagudis LLC grew its position in Intuitive Surgical by 200.0% during the 4th quarter. Sargent Bickham Lagudis LLC now owns 78 shares of the medical equipment provider’s stock worth $28,000 after acquiring an additional 52 shares during the last quarter. 83.69% of the stock is currently owned by hedge funds and other institutional investors.

Several equities analysts recently issued reports on the company. Wolfe Research assumed coverage on Intuitive Surgical in a research report on Tuesday, April 5th. They set a “peer perform” rating and a $315.00 price target on the stock. Robert W. Baird reduced their price target on Intuitive Surgical from $370.00 to $315.00 and set an “outperform” rating on the stock in a research report on Friday, January 21st. BTIG Research reduced their price target on Intuitive Surgical from $372.00 to $360.00 and set a “buy” rating on the stock in a research report on Friday, January 21st. UBS Group upgraded Intuitive Surgical from a “neutral” rating to a “buy” rating and raised their price target for the stock from $317.00 to $325.00 in a research report on Wednesday, February 2nd. Finally, StockNews.com assumed coverage on Intuitive Surgical in a research report on Thursday, March 31st. They issued a “hold” rating on the stock. Eight analysts have rated the stock with a hold rating, twelve have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of $326.60.

In other Intuitive Surgical news, EVP Myriam Curet sold 6,000 shares of Intuitive Surgical stock in a transaction on Tuesday, April 26th. The stock was sold at an average price of $252.51, for a total transaction of $1,515,060.00. Following the completion of the transaction, the executive vice president now owns 361 shares in the company, valued at $91,156.11. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.90% of the stock is currently owned by insiders.

Shares of ISRG traded up $12.00 on Friday, reaching $223.69. The stock had a trading volume of 2,250,282 shares, compared to its average volume of 2,675,108. The firm has a market capitalization of $80.30 billion, a price-to-earnings ratio of 49.75, a price-to-earnings-growth ratio of 4.81 and a beta of 1.26. The company has a 50-day simple moving average of $269.05 and a 200-day simple moving average of $303.94. Intuitive Surgical, Inc. has a 12-month low of $206.60 and a 12-month high of $369.69.

Intuitive Surgical (NASDAQ:ISRGGet Rating) last released its earnings results on Thursday, April 21st. The medical equipment provider reported $1.00 EPS for the quarter, beating analysts’ consensus estimates of $0.93 by $0.07. The company had revenue of $1.49 billion during the quarter, compared to analysts’ expectations of $1.43 billion. Intuitive Surgical had a return on equity of 14.16% and a net margin of 27.84%. The firm’s revenue for the quarter was up 15.1% compared to the same quarter last year. During the same quarter last year, the business posted $1.17 EPS. As a group, sell-side analysts predict that Intuitive Surgical, Inc. will post 4.14 earnings per share for the current fiscal year.

Intuitive Surgical Profile (Get Rating)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Featured Stories

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGGet Rating).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.